Endocrinology · Tampa, FL
NPI
1982640249
Since 2006
Specialty
Endocrinology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3226 Cove Bend Dr
Tampa, FL, 33613
Phone (813) 977-0778
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,089 services
Medicare patients, 2024
285
Average age 71
Drug cost, 2024
$2.3M
7,911 prescriptions
Company payments, 2025
$918
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad M Baig was code 99214 (office e&m - established), 465 times for 169 patients. In total Mohammad M Baig billed 1,089 services in 18 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 465 | 169 | $89.97 | $42K |
| 95251 Test - Miscellaneous | Office | 115 | 36 | $26.51 | $3,049 |
| 99232 Hospital E&M - Subsequent | Facility | 114 | 59 | $61.59 | $7,022 |
| 82947 Clinical Chemistry | Office | 111 | 62 | $3.85 | $427 |
| 99213 Office E&M - Established | Office | 108 | 73 | $61.64 | $6,657 |
| 99222 Hospital E&M - Initial | Facility | 47 | 46 | $100.90 | $4,742 |
| 99231 Hospital E&M - Subsequent | Facility | 39 | 31 | $38.12 | $1,487 |
| 99204 Office E&M - New | Office | 36 | 36 | $125.89 | $4,532 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 21 | 19 | $12.93 | $272 |
By year: 2022 $71K for 1,071 services; 2023 $70K for 1,009 services; 2024 $72K for 1,089 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 111 | 62 | $3.85 | $427 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad M Baig prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,042 prescriptions and refills. In total Mohammad M Baig wrote 7,911 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,042 | 2,135 | 242 | $8,322 |
| Ozempic Semaglutide | 566 | 720 | 114 | $603K |
| Metformin Hcl Generic | 565 | 997 | 145 | $2,561 |
| Atorvastatin Calcium Generic | 521 | 1,003 | 144 | $3,245 |
| Trulicity Dulaglutide | 419 | 510 | 70 | $488K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 270 | 489 | 77 | $40K |
| Glimepiride Generic | 235 | 396 | 50 | $1,292 |
| Methimazole Generic | 216 | 327 | 42 | $1,342 |
| Jardiance Empagliflozin | 185 | 251 | 38 | $149K |
| Rosuvastatin Calcium Generic | 152 | 334 | 47 | $1,458 |
| Pioglitazone Hcl Generic | 148 | 274 | 34 | $1,070 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 143 | 278 | 43 | $13K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 142 | 214 | 30 | $24K |
| Metformin Hcl Er Metformin Hcl | 141 | 299 | 41 | $850 |
| Tresiba Flextouch U-100 Insulin Degludec | 135 | 213 | 29 | $78K |
Brand drugs: 3,994 claims; generic drugs: 3,502 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad M Baig $918 ($918 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novo Nordisk Inc with $332.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 14 | $332 |
| Corcept Therapeutics CORT | 4 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $98.17 |
| Lilly USA, LLC LLY | 3 | $61.98 |
| Amgen Inc. AMGN | 2 | $51.77 |
| Sequel Med Tech, LLC | 2 | $45.77 |
| Xeris Pharmaceuticals, Inc. | 2 | $35.32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.18 |
| Recordati_rare_diseases_inc. | 1 | $27.6 |
| Madrigal Pharmaceuticals MDGL | 1 | $18.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.